ArticleFrontiers in medicine2026

Evaluating the real-world safety of cholestyramine for the treatment of hyperlipidemia: disproportionality analysis of FAERS data.

Qiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.